-
[Heavyweight] 3 billion domestic insulin dragon hair varieties will be approved
Time of Update: 2021-06-11
A few days ago, the marketing application of 15 kinds of therapeutic biological products protamine recombinant human insulin injection (premixed 30R) of Ganli Pharmaceutical has entered the administrative approval stage.
-
What breakthroughs are behind the 40 years of sharpening the sword and conquering the famous "unable to medicine" target
Time of Update: 2021-06-11
"Hurry up" and deliver innovative therapies to patients"Hurry up" and deliver innovative therapies to patientsAfter Professor Shokat revealed the crystal structure of the KRAS mutant's new binding "pocket" in the journal Nature, a number of biomedical companies have invested in drug research and development along this direction.
-
Simcere Pharmaceutical's "Idoxaban Toluenesulfonate Tablets" Declared for Listing
Time of Update: 2021-06-11
On June 2, the Insight database showed that Hainan Simcere Pharmaceutical’s application for the listing of 4 types of generic drug idoxaban tosylate tablets was accepted (acceptance number: CYHS2101233/4/5) for the treatment of stroke and atrial fibrillation To prevent systemic embolism, it is the first domestic producer of this species.
-
Pan Guangcheng resigned as independent director of Kailaiying
Time of Update: 2021-06-11
On June 1, Kailaiying issued an announcement stating that it had recently received a written resignation report from independent director Pan Guangcheng.
Pan Guangcheng applied for the resignation of the company's independent director, strategic committee member, and nomination committee member.
-
Chinese medicine acyclovir for injection passed the consistency evaluation of generic drugs
Time of Update: 2021-06-11
On June 2, China Pharmaceuticals issued an announcement stating that its subsidiary, Keyi Pharmaceutical, had obtained the "Notice of Approval of Supplementary Application for Drug Application" for acyclovir for injection approved and issued by the State Food and Drug Administration.
The sales revenue of this drug in China Pharmaceuticals in 2020 is approximately RMB 2.
-
ASCO 2021 highlight moment!
Time of Update: 2021-06-11
2 In terms of "Shuang Ai combination" combined with other treatments, the team of Professor Xing Wenge from Tianjin Medical University Cancer Hospital on the efficacy and safety of carrelizumab combined with apatinib combined with TACE and cryoablation in the first-line treatment of advanced hepatocellular carcinoma The design is selected for the poster link, and we look forward to the announcement of future results.
-
Department of Finance: further restrictions on imports of medical devices
Time of Update: 2021-06-11
Procurement of imported equipment will be supervised throughout the process In addition to Hangzhou, in February this year, the Guangdong Provincial Department of Finance also issued the "Notice on Optimizing Administration of Provincial Government Procurement of Imported Products", which also requires strict review of government procurement of imported products .
-
Li Lanjuan's team: The mitochondrial mechanism of necrotizing apoptosis in liver disease
Time of Update: 2021-06-10
A review published by the team of Academician Li Lanjuan from Zhejiang University School of Medicine in IJMS reviewed the various molecular mechanisms of mitochondria-mediated cell necrosis and discussed its role in a variety of liver diseases and potential clinical studies.
-
The fifth batch of national drug procurement will open bids, involving anti-cancer drugs, antihypertensive drugs, etc.
Time of Update: 2021-06-10
(China News Network)A few days ago, the National Organization for Pharmaceutical Joint Procurement Office released the fifth batch of national drug procurement product catalogs, and determined 62 varieties to participate in this procurement, including anticancer drugs, antibiotics, hypertension-related drugs, ophthalmology-related drugs, and psychotropic drugs, etc.
-
Important notice for licensed pharmacist candidates is here
Time of Update: 2021-06-10
According to the news, this year's registered pharmacist vocational qualification examination registration certificate has implemented a notification and commitment system, and applicants can choose whether to use the notification and commitment system.
-
The new patent law is officially implemented! Innovative drug patent protection period can be extended to 14 years
Time of Update: 2021-06-10
In order to compensate for the time spent in the review and approval of new drugs, the patent administration department of the State Council shall, at the request of the patentee, grant compensation for the duration of the patent right for the new drug-related invention patents that have been approved for marketing in China.
-
From monopoly of 3.5 billion to less than 200 million Bayer is besieged by 23 companies including CSPC
Time of Update: 2021-06-10
In the face of the "dilemma" of rivaroxaban that is several times fiercely competitive, will Bayer, which has "experience" with Acarbose, make the same choice this time?On June 3, the day after the fifth batch of centralized procurement documents were released, Eli Lilly announced that it had signed an agreement with Menarini, an Italian pharmaceutical company, to sell Cialis (tadalafil) to the Chinese mainland market.
-
Is the new crown vaccine every year?
Time of Update: 2021-06-10
Focusing on hot topics such as epidemic prevention and control and vaccination of public concern, experts such as Zhang Wenhong, Zheng Zhongwei, Li Lanjuan and others who came to the conference conducted discussions and exchanges and made the latest judgments.
-
Qilu broke out!
Time of Update: 2021-06-10
A few days ago, the State Food and Drug Administration's official website showed that Qilu Pharmaceutical's cefazolin sodium for injection has been approved as a supplementary application, and this product is the third domestically-evaluated company.
-
Health Commission: my country's vaccine research and development number ranks first in the world
Time of Update: 2021-06-10
National Health Commission: my country ranks first in the world in terms of the number of vaccine research and development National Health Commission: my country ranks first in the
-
ASCO 2021: TOP10 New Opportunities
Time of Update: 2021-06-10
Image source: Macrogenics official websiteAt this ASCO meeting, MGC018 announced a dose escalation study that enrolled 29 patients covering multiple tumor types, including 3 patients with recurrent melanoma who had previously received ≥2 line checkpoint treatment.
-
Who will be the domestic CXO unicorn to share the $244 billion market pie?
Time of Update: 2021-06-10
Figure 4: Statistics on the number of domestic new drug INDs The development trend of China's CXO industry Small molecule drug R&D companies are facing business transformation .
-
Gao Fu: If the vaccine is not shared, the virus will share the world
Time of Update: 2021-06-10
" On the Pujiang Innovation Forum · Global Health and Development Forum held on June 4 in the afternoon, Chinese Academy of Sciences academician , the US National Academy of Sciences foreign academician , director of high Chinese Center for Disease Control and Prevention Fu said so.
-
24 new confirmed cases, 9 of which are local cases are in Guangdong
Time of Update: 2021-06-10
As of 24:00 on June 3, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are currently 371 confirmed cases (including 8 severe cases), a total of 86,187 cured and discharged cases, and a total of 4,636 deaths.
-
Human Virome Heterogeneity Assessment Report Published
Time of Update: 2021-06-10
" Researcher Ma Zhanshan said, the difference in the virus group The qualitativeness is similar to the heterogeneity of bacteria, but the high variability of viruses also makes it more difficult to classify and identify them.
